These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13884383)

  • 1. Experimental hepatic porphyria caused by feeding 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine. Comparison with sedormid porphyria.
    DE MATTEIS F; PRIOR BE
    Biochem J; 1962 Apr; 83(1):1-8. PubMed ID: 13884383
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental porphyria. III. Hepatic type produced by sedormid.
    SCHMID R; SCHWARTZ S
    Proc Soc Exp Biol Med; 1952 Dec; 81(3):685-9. PubMed ID: 13037766
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental porphyria. IV. Studies of liver catalase and other heme enzymes in sedormid porphyria.
    SCHMID R; FIGEN JF; SCHWARTZ S
    J Biol Chem; 1955 Nov; 217(1):263-74. PubMed ID: 13271391
    [No Abstract]   [Full Text] [Related]  

  • 4. Sedormid-induced porphyria in the rat.
    CASE JD; ALDRICH RA; NEVE RA
    Proc Soc Exp Biol Med; 1953 Jul; 83(3):566-8. PubMed ID: 13088910
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
    Tephly TR; Gibbs AH; Ingall G; De Matteis F
    Int J Biochem; 1980; 12(5-6):993-8. PubMed ID: 7450161
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystalline porphobilinogen from urine of rabbits treated with sedormid.
    BROCKMAN PE; GRAY CH
    Biochem J; 1953 Jun; 54(3):xxi-xxii. PubMed ID: 13058942
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase.
    Tephly TR; Gibbs AH; De Matteis F
    Biochem J; 1979 Apr; 180(1):241-4. PubMed ID: 486100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
    Cole SP; Zelt DT; Marks GS
    Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
    [No Abstract]   [Full Text] [Related]  

  • 9. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
    Cole SP; Whitney RA; Marks GS
    Mol Pharmacol; 1981 Sep; 20(2):395-403. PubMed ID: 7300820
    [No Abstract]   [Full Text] [Related]  

  • 10. Porphyrin metabolism. IV. Molecular structure of acetamide derivatives affecting porphyrin metabolism.
    TALMAN EL; LABBE RF; ALDRICH RA
    Arch Biochem Biophys; 1957 Feb; 66(2):289-300. PubMed ID: 13403675
    [No Abstract]   [Full Text] [Related]  

  • 11. [EXPERIMENTAL PROPHYRIA INDUCED IN THE WHITE RAT BY DIETHYL 1,4-DIHYDRO-2,4,6-TRIMETHYLPYRIDINE-3,5-DICARBOXYLATE. INHIBITORY ACTION OF INOSINE ON THE EXAGGERATED PORPHYRINOGENESIS].
    GAJDOS A; GAJDOS-TOEROEK M
    Rev Fr Etud Clin Biol; 1963 Nov; 8():916-9. PubMed ID: 14096970
    [No Abstract]   [Full Text] [Related]  

  • 12. INCREASED SYNTHESIS OF L-ASCORBIC ACID CAUSED BY DRUGS WHICH INDUCE PORPHYRIA.
    DEMATTEIS F; DEMATTEIS F
    Biochim Biophys Acta; 1964 Mar; 82():641-4. PubMed ID: 14148842
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs and the hepatic porphyrias.
    Smith AG; De Matteis F
    Clin Haematol; 1980 Jun; 9(2):399-425. PubMed ID: 7398153
    [No Abstract]   [Full Text] [Related]  

  • 14. Porphyria-inducing activity of a series of pyridine and dihydropyridine compounds. Investigation in a cell culture system.
    Roomi MW
    J Med Chem; 1975 May; 18(5):457-60. PubMed ID: 1151957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice.
    De Matteis F; Abbritti G; Gibbs AH
    Biochem J; 1973 Jul; 134(3):717-27. PubMed ID: 4749272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PK 11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats.
    Fonia O; Weizman R; Coleman R; Kaganovskaya E; Gavish M
    Hepatology; 1996 Sep; 24(3):697-701. PubMed ID: 8781345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyrin metabolism. I. Experimental porphyria in chick embryos.
    TALMAN EL; CASE JD; NEVE RA; LABBE RF; ALDRICH RA
    J Biol Chem; 1955 Feb; 212(2):663-75. PubMed ID: 14353868
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria: report of two cases of acute hepatic porphyria with review of literature.
    DHIRAWANI MK
    Indian J Med Sci; 1960 Apr; 14():359-69. PubMed ID: 13816366
    [No Abstract]   [Full Text] [Related]  

  • 19. HYPERCHOLESTEROLEMIA IN EXPERIMENTAL AND HUMAN HEPATIC PORPHYRIA.
    TADDEINI L; NORDSTROM KL; WATSON CJ
    Metabolism; 1964 Aug; 13():691-701. PubMed ID: 14205114
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms.
    De Matteis F; Gibbs AH
    Biochem J; 1975 Jan; 146(1):285-7. PubMed ID: 1147902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.